Article

AAO 2019 Retina Street Team: Key takeaways

Judy E. Kim, MD; David M. Brown, MD; and Charlie C. Wykoff, MD,PhD, share their take on key highlights - what’s in the pharmaceutical pipelines, upcoming and ongoing clinical trials, and the latest update in gene therapy - from the 2019 meeting of the American Academy of Ophthalmology.

Judy E. Kim, MD; David M. Brown, MD; and Charles C. Wykoff, MD,PhD, share their take on key highlights - what’s in the pharmaceutical pipelines, upcoming and ongoing clinical trials, and the latest update in gene therapy - from the 2019 meeting of the American Academy of Ophthalmology.

Read and watch more highlights from the AAO 2019 Retina Street Team. 

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
© 2024 MJH Life Sciences

All rights reserved.